Longevity
Intelligence
Research summaries, supplement analysis, clinical trials. Connected to 20+ other domains in a knowledge graph that discovers what reading in silos never can.
Latest Findings
Recent intelligence in longevity
Rapamycin analog shows geroprotective effects without immunosuppression
Phase II data on a novel rapalog demonstrates mTORC1-selective inhibition with minimal impact on mTORC2, reducing infection risk.
Source: Nature AgingEpigenetic clock recalibration after 12-week NAD+ protocol
Interventional study (n=85) shows 2.1-year biological age reduction using combination NMN + resveratrol protocol.
Source: Cell MetabolismSenolytic combination therapy enters Phase III for osteoarthritis
Phase III enrollment for dasatinib + quercetin combination targeting senescent chondrocytes in knee OA.
Source: ClinicalTrials.govThese are example entries. Sign up to access the full intelligence feed.
What You Get
Longevity knowledge, connected
Longevity intelligence
Every relevant source monitored, scored for credibility, and connected to findings across 20+ other domains. Know what matters before it becomes consensus.
Cross-domain discovery
The real value: connections between longevity and other domains that nobody reading a single feed would ever find. A finding in one field confirming or contradicting another.
Contradiction detection
When two respected sources disagree on a topic in longevity, you see both sides immediately — with confidence scores and source credibility. No blind spots.
Free Weekly Briefing
Knowledge, delivered
A weekly briefing of the most important developments across your domains — connected to the bigger picture, not just isolated headlines.
Unsubscribe anytime. We respect your inbox.